Coeptis Therapeutics Warrants
COEPW
COEPW was delisted on the 24th of April, 2026.
13 hedge funds and large institutions have $25.1K invested in Coeptis Therapeutics Warrants in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.
158% more capital invested
Capital invested by funds: $9.72K → $25.1K (+$15.4K)
24.96% more ownership
Funds ownership: 2.06% → 27.02% (+25%)
0% more funds holding
Funds holding: 13 → 13 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.2K |
| 2 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$985 |
| 3 |
TSS
Two Sigma Securities
New York
|
+$445 |
| 4 |
CS
Clear Street
New York
|
+$4 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$189 |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$130 |
| 3 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$49 |
| 4 |
Walleye Trading
New York
|
-$24 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2 |
COEPW Hedge Fund Activity: Q2 2025 in Review
13 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q2 2025, worth a combined $25.1K — up 158% from $9.72K a quarter earlier.
Fund positioning in COEPW was balanced in Q2 2025: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.2K. The largest seller was Osaic Holdings, exiting entirely with an estimated $189 sold.
- 13 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q2 2025, unchanged from Q1 2025.
- Funds reported $25.1K of Coeptis Therapeutics Warrants stock for Q2 2025, up 158% quarter-over-quarter.
- 3 funds opened new Coeptis Therapeutics Warrants positions in Q2 2025 and 3 closed out, a net change of 0 holders.
- The largest Coeptis Therapeutics Warrants buyer in Q2 2025 was Susquehanna International Group, an estimated $1.2K added.
- The largest Coeptis Therapeutics Warrants seller in Q2 2025 was Osaic Holdings, an estimated $189 sold.
Based on aggregated 13F filings for Q2 2025.